PKM and endometrial cancer: For diagnostic biomarker panels, MMP9 and PKM were reliable for discriminating endometrial cancer, while the combination of CTNB1, XPO2, and CAPG revealed higher performance in distinguishing endometrioid from serous endometrial cancer types [52].